PharmaShots | Incisive News in 3 Shots

Subscribe Now

Extensive-Stage

AstraZeneca's Imfinzi (durvalumab) Receives MHLW's Approval for Extensive-Stage Small Cell Lung Cancer

AstraZeneca's Imfinzi (durvalumab) Receives MHLW's Approval for Extensive-Stage Small Cell Lung Cancer

August 21, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us